5^th International Conference and Exhibition on Pharmaceutical Regulatory Affairs August 03-05, 2015 Florida, USA

Dr. Zhou is a professor in the School of Health Sciences at the Royal Melbourne Institute of Technology RMIT University in Australia. Having originally studied and practiced clinical medicine in China he undertook his PhD in pharmacology at the University of Auckland, New Zealand and has also worked at the National University of Singapore and the Queensland University of Technology. He is currently affiliated with the WHO Collaborating Center for Traditional Medicine. Professor Zhou is the editor of Drug Metabolism Letters and acts as a guest editor for Current Pharmaceutical Design and Current Drug Metabolism.

Pharmacokinetics, Pharmacogenetics, evaluation of herbal medicines and drug delivery.

Adam Sabouni is the Managing Partner for PharmaConsultz. He was the Chief Development Offi cer at Novan Therapeutics. He has served as the Global VP,Pharmaceutical Sciences and Process Development at Stiefel Laboratories. He was responsible for 5 R&D sites and supported 6 Manufacturing facilities. He has 25 years of experience in PD, manufacturing, compliance, and remediation. At Pfizer, he was responsible for the remediation action plan to lift the cGMP-related consent decree. He is a Pharmacist and has a PhD in pharmaceutical sciences from the University of Bonn.

Pharmaceuticals, Manufacturing

Donald is a Senior Scientific Liaison in USP. His responsibilities include monograph development and review, in particular the chemical medicine monograph modernization initiated by USP laboratories. After completed his PhD at Montana State University and post doc training at University of Missouri, he had spent over 20 years in analytical method development/validation and solid-state characterization in support of pharmaceutical R&D and quality operations. Prior to joining USP, Donald was manager for global quality support and technical lead for compendial compliance, at Schering-Plough/Merck.

validation, pharmaceutical R&D and quality operations

Michael Drues, Ph.D., is President of Vascular Sciences, an education, training, & consulting company offering a broad range of services to medical device, pharmaceutical & biotechnology companies including (but not limited to): stimulating & innovative educational programing, brain-storming sessions, prototype design, product development, benchtop & animal testing, innovative regulatory strategy & completive regulatory intelligence, clinical trial design, FDA presentation preparation & defense, reimbursement, clinical acceptance, business development & technology assessment.

Biotechnology,medical device and benchtop & animal testing.

Rama Pidaparti is a Ph.D. candidate from ASU and attended a Lifesciences and HealthCare courses from BEP Program at Sloan School of Management, MIT. Has over 20 years of industry experience and is currently Principal Consultant, Medical Devices vertical,Wipro Technologies, USA. Has worked at many large Global Medical Devices and Bio-Tech drug companies as a consultant, GEHC, J&J, Genzyme, Genentec, Zimmer, to name a few. He has been helping the clients with Processes and Validated implementations of Computerized Systems for R&D, Quality and Regulatory areas. He is an invited speaker on Quality and Compliance topics at similar events in the past 10 years.

HealthCare and pharmacy

Fabio Grizzi

Fabio Grizzi

Vladimir V Popov, MD DrScMed, is CEO and Medical Director of CRO, ESMAR. He is the Head of Clinical Pharmacology, Dept NGHCI "Scientific Medical Center" JSC "Russian Railways" Leading researcher of Department of Cardiology 1st Moscow State Medical University named after Sechenov. Previously he was an Assistant Professor. (part time) Department of Internal Medicine No.1, Faculty of Post-graduate Education, Moscow University of Medicine and Dentistry, Moscow, Russia. He was also a Scientific researcher (MD), Department of Clinical Pharmacology, Institute of Therapy, Academy of Medical Science of Ukraine, Ukraine.

Cardiology, Clinical Pharmacology

David Hawley is Director of Life Sciences at Business & Decision North America. Twenty years later he left the company which by that time was part of the Pfizer group, having worked in Engineering, shop-floor Production Management of Pharmaceuticals and Medical Devices, and various roles in information technology. Since joining the Business & Decision group in 2004 he has worked on more than forty projects in the UK, Europe, North America, Asia and elsewhere, specialising in the compliance of infrastructure and large configurable systems such as ERP systems. He has worked on SAP , Oracle EBS, Microsoft AX, Epicor, Plex and others.

Medical Devices, Pharmaceuticals and Engineering

Senior Scientist

Senior Scientist

Mohamed Eddouks

Mohamed Eddouks

Dr. Rajiv Mahendru possessed Post-Graduate Degree in Obstetrics and Gynaecology from Himachal Pradesh University at the age of 29 years and became one of the youngest Professors. Presently, Head of the Department in the only second women medical college of India. He has 41 Publications in reputed journals and is the recipient of a prestigious Award for excellence in Medical field. Appointed as the Chief-editor of the Special issue of an international journal of repute and has numerous presentations to his credit at international arena as an invited Guest Speaker. He is the member of editorial board of international journals, Academic Board of many universities, member of recruitment for medical teachers, and assessor for establishing Medical colleges. He has chaired numerous sessions in the National and International conferences.

Medical and Drugs